美国路明克斯 Luminex  www.luminexcorp.com
Luminex公司成立于1995年，总部位于美国德克萨斯州的奥斯汀，于2000年在美国纳斯达克上市，公司的xMAP（multi-analyte profiling）开放式结构平台，在流式细胞技术、ELISA技术和芯片技术基础上，有机地整和了编码微球、激光技术、应用流体学、最新的高速数字信号处理器和计算机运算法则，能带来快速、准确、经济的分析结果，广泛应用于免疫分析、核酸研究、酶学分析、受体和配体识别分析等研究得到各权威机构和医学界高度认可，是临床诊断领域以及生命科学研究中的一大热点。
“液态芯片”xMAP技术是美国纳斯达克上市公司Luminex研制出的后基因组时代技术平台。Luminex公司是纳斯达克生物技术指数股的成员，被福布斯（Forbes）杂志评为２００１年美国第二活跃的生物技术公司。

Luminex Corporation was incorporated in May 1995 and began commercial production of our first generation system in 1997. Luminex® (NASDAQ: LMNX) develops, manufactures and markets innovative biological testing technologies with applications throughout the life science and diagnostic industries. The company’s open-architecture xMAP® technology enables large numbers of biological tests (bioassays) to be conducted and analyzed quickly, cost-effectively and accurately. 
Systems using xMAP technology perform discrete bioassays on the surface of color-coded beads known as microspheres, which are then read in a compact analyzer. Using lasers and high-speed digital-signal processors, the analyzer simultaneously identifies the bioassay and measures the results, all in real time.
Luminex Vision Statement
Worldwide Leader in Multiplexed Solutions